UZBEK LINGUISTICS: PUNCTUATION PROBLEMS AND SOLUTIONS
Journal of Universal Science Research · 14.06.2026 · 4 (Maxsus son-3) · 1478-1484
DOI: 10.66301/4225gh28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Universal Science Research, online erschienen am 14.06.2026. Verfasst von Shoira Xabibullayeva. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article analyzes the theoretical foundations of the punctuation system in Uzbek linguistics, its functional significance in written speech, and punctuation problems arising in the modern communicative environment. During the study, the normative inconsistencies observed in the use of commas, dashes, hyphens, colons, semicolons, quotation marks, and colons were studied. Also, the processes of punctuation simplification occurring in Uzbek written speech under the influence of Internet discourse, social networks, and instant messaging were scientifically explained. The article interprets punctuation not merely as a technical writing phenomenon, but as a complex system related to syntax, semantics, pragmatics, and text linguistics. Based on the research results, scientific and practical recommendations were developed to improve punctuation literacy, enhance the normative base, create electronic corpora, and introduce functional punctuation methodology into the educational process.
Zitieren
APA
Xabibullayeva, S. (2026). UZBEK LINGUISTICS: PUNCTUATION PROBLEMS AND SOLUTIONS. Journal of Universal Science Research, 4(Maxsus son-3), 1478-1484. https://doi.org/10.66301/4225gh28
Vancouver
Xabibullayeva S. UZBEK LINGUISTICS: PUNCTUATION PROBLEMS AND SOLUTIONS. Journal of Universal Science Research. 2026;4(Maxsus son-3):1478-1484. doi:10.66301/4225gh28
BibTeX
@article{Xabibullayeva2026,
author = {Xabibullayeva, Shoira},
title = {UZBEK LINGUISTICS: PUNCTUATION PROBLEMS AND SOLUTIONS},
journal = {Journal of Universal Science Research},
year = {2026},
volume = {4},
number = {Maxsus son-3},
pages = {1478--1484},
doi = {10.66301/4225gh28}
}
EUVIMED